100 related articles for article (PubMed ID: 30563826)
21. Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.
Le Rhun E; Bertrand N; Dumont A; Tresch E; Le Deley MC; Mailliez A; Preusser M; Weller M; Revillion F; Bonneterre J
Eur J Cancer; 2017 Dec; 87():189-198. PubMed ID: 29103666
[TBL] [Abstract][Full Text] [Related]
22. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
[TBL] [Abstract][Full Text] [Related]
23. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel Breast Cancer Risk Loci.
Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
[TBL] [Abstract][Full Text] [Related]
25. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
26. Performance of common genetic variants in breast-cancer risk models.
Wacholder S; Hartge P; Prentice R; Garcia-Closas M; Feigelson HS; Diver WR; Thun MJ; Cox DG; Hankinson SE; Kraft P; Rosner B; Berg CD; Brinton LA; Lissowska J; Sherman ME; Chlebowski R; Kooperberg C; Jackson RD; Buckman DW; Hui P; Pfeiffer R; Jacobs KB; Thomas GD; Hoover RN; Gail MH; Chanock SJ; Hunter DJ
N Engl J Med; 2010 Mar; 362(11):986-93. PubMed ID: 20237344
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
28. Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients.
Yin JY; Li X; Li XP; Xiao L; Zheng W; Chen J; Mao CX; Fang C; Cui JJ; Guo CX; Zhang W; Gao Y; Zhang CF; Chen ZH; Zhou H; Zhou HH; Liu ZQ
Cancer Lett; 2016 Jul; 377(1):65-73. PubMed ID: 27126360
[TBL] [Abstract][Full Text] [Related]
29. A pilot genome-wide association study of breast cancer susceptibility loci in Indonesia.
Haryono SJ; Datasena IG; Santosa WB; Mulyarahardja R; Sari K
Asian Pac J Cancer Prev; 2015; 16(6):2231-5. PubMed ID: 25824743
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
Yu KD; Rao NY; Chen AX; Fan L; Yang C; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 126(1):37-45. PubMed ID: 20390341
[TBL] [Abstract][Full Text] [Related]
31. SNPs related to vitamin D and breast cancer risk: a case-control study.
Huss L; Butt ST; Almgren P; Borgquist S; Brandt J; Försti A; Melander O; Manjer J
Breast Cancer Res; 2018 Jan; 20(1):1. PubMed ID: 29291743
[TBL] [Abstract][Full Text] [Related]
32. Lack of effects of peroxisome proliferator-activated receptor gamma genetic polymorphisms on breast cancer risk: a case-control study and pooled analysis.
Park B; Shin A; Kim KZ; Lee YS; Hwang JA; Kim Y; Sung J; Yoo KY; Lee ES
Asian Pac J Cancer Prev; 2014; 15(21):9093-9. PubMed ID: 25422184
[TBL] [Abstract][Full Text] [Related]
33. Re: Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk.
Spitz MR; Amos CI; D'Amelio A; Dong Q; Etzel C
J Natl Cancer Inst; 2009 Dec; 101(24):1731-2; author reply 1732. PubMed ID: 19903803
[No Abstract] [Full Text] [Related]
34. Combining risk markers improves cardiovascular risk prediction in women.
Holewijn S; den Heijer M; Kiemeney LA; Stalenhoef AF; de Graaf J
Clin Sci (Lond); 2014 Jan; 126(2):139-46. PubMed ID: 23879211
[TBL] [Abstract][Full Text] [Related]
35. MSH2 rs2303425 Polymorphism is Associated with Early-Onset Breast Cancer in Taiwan.
Hsieh YC; Cho EC; Tu SH; Wu CH; Hung CS; Hsieh MC; Su CT; Liu YR; Lee CH; Ho YS; Chiou HY
Ann Surg Oncol; 2017 Feb; 24(2):603-610. PubMed ID: 26975740
[TBL] [Abstract][Full Text] [Related]
36. Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung Project.
Raji OY; Agbaje OF; Duffy SW; Cassidy A; Field JK
Cancer Prev Res (Phila); 2010 May; 3(5):664-9. PubMed ID: 20424129
[TBL] [Abstract][Full Text] [Related]
37. Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies.
Dashti S; Taherian-Esfahani Z; Keshtkar A; Ghafouri-Fard S
BMC Med Genet; 2019 May; 20(1):79. PubMed ID: 31077156
[TBL] [Abstract][Full Text] [Related]
38. Association between
Wen J; Lv Z; Ding H; Fang X; Sun M
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654162
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
